Chargement en cours...

Cued memory decline in biomarker-defined preclinical Alzheimer disease

OBJECTIVE: To determine whether a decline in cued recall is observable in the preclinical stage of Alzheimer disease (AD) in clinically normal older adults with elevated β-amyloid (Aβ) burden on PET imaging. METHODS: Clinically normal older adults underwent baseline neuroimaging (PET to assess Aβ(+/...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neurology
Auteurs principaux: Papp, Kathryn V., Rentz, Dorene M., Mormino, Elizabeth C., Schultz, Aaron P., Amariglio, Rebecca E., Quiroz, Yakeel, Johnson, Keith A., Sperling, Reisa A.
Format: Artigo
Langue:Inglês
Publié: Lippincott Williams & Wilkins 2017
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5386436/
https://ncbi.nlm.nih.gov/pubmed/28283594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003812
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!